Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LPLA compared with COLL: revenue, margins and what each company keeps, and the suppliers and customers both name
LPLA
LPL Financial Holdings Inc.
Change
Mkt cap
Revenue
Revenue
COLL
Collegium Pharmaceutical, Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
LPLA
LPL Financial Holdings Inc.
vs
COLL
Collegium Pharmaceutical, Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
LPLA
1 of 1
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±8.6%
▼
−15.23%
×1.77
Q2 FY26
—
▲
+4.28%
—
Q1 FY26
—
▼
−4.64%
—
Jan 30 '26
—
▲
+0.49%
—
COLL
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
thin chain
±20.4%
▲
+6.29%
×0.31
Q2 FY26
±12.2%
▼
−18.55%
×1.52
= implied
LPLA realized, solid
COLL realized, hatched
One scale, both sides: full bar = 21%
× = |realized| ÷ implied
Source: market data
May 7 '26
±12.6%
▲
+7.72%
×0.61
Q1 FY26
±7.7%
▼
−3.34%
×0.43
LPLA
LPL Financial Holdings Inc.
Change
294.76
▼
−2.04%
· post 294.76
Mkt cap
$23.0B
Revenue
$5.3B
Q3 FY26
Revenue
$17.0B
FY25
COLL
Collegium Pharmaceutical, Inc
Change
24.23
▼
−3.71%
· post 24.23
Closed
Nov 6 '26
Mkt cap
$752.3M
Revenue
$216M
Q3 FY26
Revenue
$781M
FY25
vs
Compare
Closed
Nov 6 '26
LPLA
LPL Financial Holdings Inc.
vs
COLL
Collegium Pharmaceutical, Inc
294.76
▼
−2.04%
post 294.76
Price
24.23
▼
−3.71%
post 24.23
$23.0B
Mkt cap
$752.3M
Q3 FY26
$5.3B
Revenue
$216M
Q3 FY26
FY25
$17.0B
Revenue
$781M
FY25
Change
Change
LPLA
294.76
▼
−2.04%
vs
COLL
24.23
▼
−3.71%
Closed
Nov 6 '26